Klaria Pharma Holding AB (OSTO:KLAR) Tariff Resilience Score: 0/10 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:KLAR Klaria Pharma Holding AB OSTO:KLAR
9 GF Score
Price kr0.79
GF Value kr0.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB Tariff Resilience Score?

Klaria Pharma Holding AB has the Tariff Resilience Score of 0, which implies that the company might have .

Klaria Pharma Holding AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Klaria Pharma Holding AB might have .

Klaria Pharma Holding AB  (OSTO:KLAR) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Klaria Pharma Holding AB Tariff Resilience Score Related Terms

OSTO:KLAR
9GF Score
Klaria Pharma Holding AB OSTO:KLAR
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of kr0.79 is trading 146.3% above its estimated GF Value™ of kr0.32. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:KLAR:

  • Tariff Resilience Score: 0
  • GF Value™: kr0.32 vs. price of kr0.79 (146.3% above fair value)
  • GF Score™: 9/100 with 6 warning signs

No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klaria Pharma Holding AB Business Description

Other Exchanges 6FN:Germany
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
9GF Score

Get the complete analysis for OSTO:KLAR

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.79
Price
kr0.32
GF Value